アメリカの急性虚血性脳卒中の診断と治療市場2017

【英語タイトル】United States Acute Ischemic Stroke Diagnosis and Treatment Market Report 2017

QYResearchが出版した調査資料(QYR70505752)・商品コード:QYR70505752
・発行会社(調査会社):QYResearch
・発行日:2017年4月12日
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ
・産業分野:バイオ・医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,800 ⇒換算¥418,000見積依頼/購入/質問フォーム
EnterpriseUSD7,600 ⇒換算¥836,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、アメリカの急性虚血性脳卒中の診断と治療市場について調査・分析し、急性虚血性脳卒中の診断と治療のアメリカ市場概観、急性虚血性脳卒中の診断と治療の種類別市場分析、用途別市場分析、急性虚血性脳卒中の診断と治療のアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・急性虚血性脳卒中の診断と治療のアメリカ市場概観
・急性虚血性脳卒中の診断と治療の種類別市場規模
・急性虚血性脳卒中の診断と治療の用途別市場規模
・急性虚血性脳卒中の診断と治療のアメリカ市場規模
・急性虚血性脳卒中の診断と治療のアメリカ市場予測
・急性虚血性脳卒中の診断と治療の製造メーカー分析
・急性虚血性脳卒中の診断と治療のメーカー別生産量
・急性虚血性脳卒中の診断と治療のメーカー別市場シェア
・急性虚血性脳卒中の診断と治療の価格動向・価格分析
・急性虚血性脳卒中の診断と治療の販売(売上高)動向
・急性虚血性脳卒中の診断と治療の貿易(輸出・輸入)動向
・急性虚血性脳卒中の診断と治療の産業チェーン分析
・急性虚血性脳卒中の診断と治療のマーケティング戦略分析
・急性虚血性脳卒中の診断と治療の販売業者(代理店)リスト
・急性虚血性脳卒中の診断と治療の市場環境分析
...
【レポートの概要】

In this report, the United States Acute Ischemic Stroke Diagnosis and Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Acute Ischemic Stroke Diagnosis and Treatment in these regions, from 2012 to 2022 (forecast).

United States Acute Ischemic Stroke Diagnosis and Treatment market competition by top manufacturers/players, with Acute Ischemic Stroke Diagnosis and Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GE Healthcare
Guerbet Group
Neusoft Medical Systems
Philips Healthcare
Siemens Healthcare
Toshiba Medical Systems Corporation
Agfa Healthcare
Analogic
Canon U.S.A., Inc.
Biosound Esaote, Inc.
Hologic, Inc.
Positron Corporation
Shimadzu
Orthoscan
Medtronic
Carestream Health

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Diagnosis devices
Treatment devices
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Acute Ischemic Stroke Diagnosis and Treatment for each application, including
Below 40 years old
Above 40 years old

【レポートの目次】

Table of Contents

United States Acute Ischemic Stroke Diagnosis and Treatment Market Report 2017
1 Acute Ischemic Stroke Diagnosis and Treatment Overview
1.1 Product Overview and Scope of Acute Ischemic Stroke Diagnosis and Treatment
1.2 Classification of Acute Ischemic Stroke Diagnosis and Treatment by Product Category
1.2.1 United States Acute Ischemic Stroke Diagnosis and Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Acute Ischemic Stroke Diagnosis and Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Diagnosis devices
1.2.4 Treatment devices
1.3 United States Acute Ischemic Stroke Diagnosis and Treatment Market by Application/End Users
1.3.1 United States Acute Ischemic Stroke Diagnosis and Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Below 40 years old
1.3.3 Above 40 years old
1.4 United States Acute Ischemic Stroke Diagnosis and Treatment Market by Region
1.4.1 United States Acute Ischemic Stroke Diagnosis and Treatment Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2012-2022)
1.4.3 Southwest Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2012-2022)
1.4.5 New England Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2012-2022)
1.4.6 The South Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2012-2022)
1.4.7 The Midwest Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Acute Ischemic Stroke Diagnosis and Treatment (2012-2022)
1.5.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Growth Rate (2012-2022)
1.5.2 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2012-2022)

2 United States Acute Ischemic Stroke Diagnosis and Treatment Market Competition by Players/Suppliers
2.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Acute Ischemic Stroke Diagnosis and Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Acute Ischemic Stroke Diagnosis and Treatment Market Competitive Situation and Trends
2.4.1 United States Acute Ischemic Stroke Diagnosis and Treatment Market Concentration Rate
2.4.2 United States Acute Ischemic Stroke Diagnosis and Treatment Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Acute Ischemic Stroke Diagnosis and Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 United States Acute Ischemic Stroke Diagnosis and Treatment Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Acute Ischemic Stroke Diagnosis and Treatment Price by Region (2012-2017)

4 United States Acute Ischemic Stroke Diagnosis and Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Acute Ischemic Stroke Diagnosis and Treatment Price by Type (2012-2017)
4.4 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Type (2012-2017)

5 United States Acute Ischemic Stroke Diagnosis and Treatment Sales (Volume) by Application (2012-2017)
5.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Acute Ischemic Stroke Diagnosis and Treatment Players/Suppliers Profiles and Sales Data
6.1 GE Healthcare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Guerbet Group
6.2.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Guerbet Group Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Neusoft Medical Systems
6.3.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Neusoft Medical Systems Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Philips Healthcare
6.4.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Philips Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Siemens Healthcare
6.5.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Siemens Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Toshiba Medical Systems Corporation
6.6.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Toshiba Medical Systems Corporation Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Agfa Healthcare
6.7.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Agfa Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Analogic
6.8.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Analogic Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Canon U.S.A., Inc.
6.9.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Canon U.S.A., Inc. Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Biosound Esaote, Inc.
6.10.2 Acute Ischemic Stroke Diagnosis and Treatment Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Biosound Esaote, Inc. Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Hologic, Inc.
6.12 Positron Corporation
6.13 Shimadzu
6.14 Orthoscan
6.15 Medtronic
6.16 Carestream Health

7 Acute Ischemic Stroke Diagnosis and Treatment Manufacturing Cost Analysis
7.1 Acute Ischemic Stroke Diagnosis and Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Acute Ischemic Stroke Diagnosis and Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Acute Ischemic Stroke Diagnosis and Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Acute Ischemic Stroke Diagnosis and Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Acute Ischemic Stroke Diagnosis and Treatment Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Acute Ischemic Stroke Diagnosis and Treatment
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Market Size (K Units) by Type (2012-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnosis devices Product Picture
Figure Treatment devices Product Picture
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Acute Ischemic Stroke Diagnosis and Treatment by Application in 2016
Figure Below 40 years old Examples
Figure Above 40 years old Examples
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units) and Growth Rate (2012-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Players/Suppliers
Figure 2017 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Players/Suppliers
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Players/Suppliers
Table United States Market Acute Ischemic Stroke Diagnosis and Treatment Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Acute Ischemic Stroke Diagnosis and Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Market Share of Top 3 Players/Suppliers
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Acute Ischemic Stroke Diagnosis and Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Acute Ischemic Stroke Diagnosis and Treatment Product Category
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units) by Region (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Region (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Region (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share by Region in 2016
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Region (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Region (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Region in 2016
Table United States Acute Ischemic Stroke Diagnosis and Treatment Price (USD/Unit) by Region (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units) by Type (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Type (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Type (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share by Type in 2016
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Acute Ischemic Stroke Diagnosis and Treatment by Type (2012-2017)
Figure Revenue Market Share of Acute Ischemic Stroke Diagnosis and Treatment by Type in 2016
Table United States Acute Ischemic Stroke Diagnosis and Treatment Price (USD/Unit) by Types (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Type (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units) by Application (2012-2017)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share by Application (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share by Application (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share by Application in 2016
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Application (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Guerbet Group Basic Information List
Table Guerbet Group Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Guerbet Group Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Guerbet Group Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Guerbet Group Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Neusoft Medical Systems Basic Information List
Table Neusoft Medical Systems Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neusoft Medical Systems Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Neusoft Medical Systems Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Neusoft Medical Systems Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Philips Healthcare Basic Information List
Table Philips Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Philips Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Philips Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Philips Healthcare Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Siemens Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Siemens Healthcare Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Toshiba Medical Systems Corporation Basic Information List
Table Toshiba Medical Systems Corporation Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Toshiba Medical Systems Corporation Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Toshiba Medical Systems Corporation Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Toshiba Medical Systems Corporation Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Agfa Healthcare Basic Information List
Table Agfa Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Agfa Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Agfa Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Agfa Healthcare Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Analogic Basic Information List
Table Analogic Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Analogic Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Analogic Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Analogic Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Canon U.S.A., Inc. Basic Information List
Table Canon U.S.A., Inc. Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Canon U.S.A., Inc. Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Canon U.S.A., Inc. Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Canon U.S.A., Inc. Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Biosound Esaote, Inc. Basic Information List
Table Biosound Esaote, Inc. Acute Ischemic Stroke Diagnosis and Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosound Esaote, Inc. Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate (2012-2017)
Figure Biosound Esaote, Inc. Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share in United States (2012-2017)
Figure Biosound Esaote, Inc. Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in United States (2012-2017)
Table Hologic, Inc. Basic Information List
Table Positron Corporation Basic Information List
Table Shimadzu Basic Information List
Table Orthoscan Basic Information List
Table Medtronic Basic Information List
Table Carestream Health Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acute Ischemic Stroke Diagnosis and Treatment
Figure Manufacturing Process Analysis of Acute Ischemic Stroke Diagnosis and Treatment
Figure Acute Ischemic Stroke Diagnosis and Treatment Industrial Chain Analysis
Table Raw Materials Sources of Acute Ischemic Stroke Diagnosis and Treatment Major Players/Suppliers in 2016
Table Major Buyers of Acute Ischemic Stroke Diagnosis and Treatment
Table Distributors/Traders List
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume (K Units) Forecast by Type in 2022
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume (K Units) Forecast by Application in 2022
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



★調査レポート[アメリカの急性虚血性脳卒中の診断と治療市場2017] (コード:QYR70505752)販売に関する免責事項を必ずご確認ください。
★調査レポート[アメリカの急性虚血性脳卒中の診断と治療市場2017]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆